By Caroline Valetkevitch
(Reuters) - U.S. stocks rallied on Thursday after two days of losses, led by a jump in financial shares following upbeat results from Citigroup.
The S&P 500 health care index was also up sharply, despite a disappointing forecast from HCA Holdings , which fell 5 percent at $72.24. The Nasdaq Biotech Index <.NBI> was up 3.8 percent.
Citigroup rose 4.8 percent to $53.15 after the third-biggest U.S. bank's results beat estimates, while Goldman Sachs was up 1.3 percent at $181.86, despite weak results.
The financial sector <.SPSY> rose 2.2 percent, recovering from losses Wednesday when JPMorgan results disappointed.
The market's gains follow two days of declines and increased worries about the outlook for U.S. earnings. As the earnings season gathers steam, investors will be scrutinizing results and forecasts for any signs of an impact from a slowing global economy.
Advancing issues outnumbered declining ones on the NYSE by 2,449 to 616, for a 3.98-to-1 ratio on the upside; on the Nasdaq, 2,262 issues rose and 563 fell, for a 4.02-to-1 ratio favoring advancers.
"Everything is having a pretty good move, even the financials," said Frank Gretz, market analyst and technician for brokerage Wellington Shields & Co in New York.
"It just got washed out enough, so I think we're in the midst of a year-end rally, thought obviously it isn't going to go straight up."
At 3:16 p.m., the Dow Jones industrial average rose 190.67 points, or 1.13 percent, to 17,115.42, the S&P 500 gained 26.28 points, or 1.32 percent, to 2,020.52 and the Nasdaq Composite added 73.09 points, or 1.53 percent, to 4,855.94.
Data showed U.S. consumer prices declined the most in eight months as gasoline costs fell in September, but a rise in core CPI, which strips out food and energy costs, suggested inflation was starting to firm.
Unemployment benefit claims, however, fell in the last week, pointing to a strong labor market.
The data, coming on the back of weak retail sales, added to the uncertainty over the timing of an interest rate increase as the Federal Reserve waits for signs of stabilizing global economy.
(Additional reporting by Abhiram Nandakumar in Bengaluru; Editing by Saumyadeb Chakrabarty and Nick Zieminski)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
